Scott Anderson, MD
Infectious Disease · Baton Rouge, LANPI 1114285293
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $201 and has fallen 64.6% since, to $71 in 2025.
Across 45 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$181
- Amgen$132
- Viiv Healthcare Company$61
- Teva Pharmaceuticals USA, Inc.$60
- Shionogi Inc$58
- Insmed, Inc.$51
- plus $394 from 16 others
What the payments were for
- Food & beverage$92198%
- Education$162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $181 |
| Amgen | 5 | $132 |
| Viiv Healthcare Company | 4 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $60 |
| Shionogi Inc | 2 | $58 |
| Insmed, Inc. | 3 | $51 |
| Argenx US, Inc. | 2 | $50 |
| Melinta Therapeutics, LLC | 2 | $48 |
| EMD Serono, Inc. | 2 | $36 |
| Springworks Therapeutics, Inc. | 1 | $30 |
| Merck | 2 | $28 |
| Qapel Medical Inc | 1 | $26 |
| Seqirus USA Inc | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $11 |
How this compares
$937 in reported general payments places this provider in the 55th percentile of 105 infectious disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxacillin Sodium | 24 | $21,185 |
| Daptomycin | 58 | $16,696 |
| ErtapenemErtapenem Sodium | 13 | $7,953 |
| Cefepime Hcl | 44 | $7,127 |
| Vancomycin Hcl | 21 | $5,586 |
| Imipenem-Cilastatin SodiumImipenem/Cilastatin Sodium | 23 | $4,379 |
| Linezolid | 26 | $2,748 |
| CeftriaxoneCeftriaxone Sodium | 40 | $2,693 |
| Doxycycline Hyclate | 108 | $2,561 |
| Rifampin | 33 | $2,516 |
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 11 | $2,422 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $1,670 |
| Levofloxacin | 22 | $1,353 |
| Clindamycin Hcl | 30 | $938 |
| Minocycline Hcl | 18 | $862 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Baton Rouge
- Walter CampbellBaton Rouge$6K
- Waref AzmehBaton Rouge$2K
- Maria Reyes AngelesBaton Rouge$2K
- Breanna CampbellBaton Rouge$1K
- Patrick NjokuBaton Rouge$979
- Shobha Rani VootukuriBaton Rouge$881
- Madeleine HeckBaton Rouge$611
- John NnadiBaton Rouge$491
- Hector Brunet RodriguezShreveport$592K
- Guillermo Padilla-PinedaShreveport$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.